Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.
Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.
AdaptHealth (AHCO) appointed Harriss T. Currie as Chief Financial Officer, effective September 9, 2026, succeeding Jason Clemens.
Clemens will assist the finance leadership transition through October 1, 2026. Currie previously served more than 15 years as CFO of Luminex (LMNX) until its sale to DiaSorin in 2021, later holding CFO roles at Health Track Rx and Impulse Dynamics and serving as President of the Regenerative Medicine division of 3D Systems (DDD). The company describes a strong leadership team, established financial processes, and strategic contracts that it believes position the business for future revenue and EBITDA growth.
ReDream Brands, backed by Cathay Capital, has launched as a new direct-to-consumer sleep health platform focused on cash-pay obstructive sleep apnea (OSA) customers across North America, uniting four established brands: cpap.com, The CPAP Shop, Lofta, and sleeping.com.
The launch follows a joint venture between cpap.com and AdaptHealth (NASDAQ: AHCO) that combined cpap.com, sleeping.com, and The CPAP Shop, plus the subsequent acquisition of Lofta. Supported by a new credit facility led by Twin Brook Capital Partners, the integrated platform ships over 700,000 customer orders annually from three U.S. warehouses and aims to expand digital engagement, diagnostics, education, and long-term customer support.
AdaptHealth (NASDAQ: AHCO) announced participation in two investor events. The company will join the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026, featuring a 9:00–9:25 a.m. ET fireside chat, and the RBC Nashville Bus Tour on August 12, 2026, 9:00–9:50 a.m. CT. CEO Suzanne Foster and CFO Jason Clemens will present.
AdaptHealth (NASDAQ: AHCO) reported second quarter 2026 net revenue of $740.3 million, up 12.7% year over year, and 15.9% organic growth across all segments. Net loss attributable to AdaptHealth was $145.3 million versus net income of $4.2 million, primarily due to a $144.2 million pre-tax goodwill impairment, while Adjusted EBITDA declined 3.2% to $132.0 million.
The company agreed to sell its Diabetes Health business for $235.0 million in cash, which will be reported as discontinued operations, and revised 2026 guidance to net revenue of $2.85–$2.89 billion, Adjusted EBITDA of $490–$520 million, and free cash flow of $80–$120 million. Guidance reflects the Diabetes Health reclassification, impacts from a West Coast capitated contract, a manufacturer price increase, and other portfolio actions. AdaptHealth also entered a sleep-focused eCommerce joint venture, completed a workforce restructuring targeting $19 million in annualized savings, redeemed its 6.125% senior notes due 2028 with a delayed draw term loan, and grew myAPP users to over 512,000, up 56% from year end 2025.
Cardinal Health (NYSE: CAH) announced definitive agreements to acquire AdaptHealth's Diabetes Health business and all of Strive Medical for a combined purchase price of approximately $360 million in cash, subject to working capital adjustments. The deals support Cardinal Health's at-Home Solutions growth strategy in diabetes management and urology.
According to Cardinal Health, AdaptHealth's Diabetes Health business serves more than 225,000 people annually via a centralized mail-order, direct-to-patient model, while Strive Medical serves more than 20,000 people annually in urology, wound care, ostomy and incontinence. Building on the earlier Advanced Diabetes Supply acquisition, Cardinal Health reports it has migrated all ADS volume to its at-Home Solutions network, onboarded nearly 500,000 new customers, and launched the ContinuCare Pathway digital referral program. The new transactions are subject to customary closing conditions, including regulatory approvals, and are expected to be accretive to non-GAAP EPS within 12 months after closing.
AdaptHealth (NASDAQ: AHCO) has signed a definitive agreement to divest its Diabetes Health business to Cardinal Health for $235 million in cash, subject to customary purchase price adjustments. The agreement was signed on July 19, 2026 and remains subject to Hart-Scott-Rodino antitrust review and other standard closing conditions.
According to AdaptHealth, the divestiture continues a multi‑year portfolio reshaping to focus on core Sleep Health, Respiratory Health, and supporting home medical equipment businesses, with an emphasis on delivering clinical value in patients’ homes. The company expects the transaction to increase capital flexibility for reinvestment in core businesses and debt reduction, and to improve its anticipated revenue growth profile and adjusted EBITDA margins going forward. AdaptHealth plans to provide a detailed update on financial and guidance implications, including treatment of Diabetes Health as a discontinued operation, on its Q2 2026 earnings call on August 4, 2026.
AdaptHealth (NASDAQ: AHCO) will release its second quarter 2026 financial results before market open on Tuesday, August 4, 2026. Management will host an earnings conference call at 8:30 a.m. ET for analysts and investors, with phone and webcast access plus a six-month replay on its investor relations website.
AdaptHealth (NASDAQ: AHCO) will participate in two investor conferences in May 2026: the Bank of America Global Healthcare Conference in Las Vegas on May 12, 2026 (fireside chat at 9:20 a.m. PT) and the RBC Global Healthcare Conference in New York on May 19, 2026 (fireside chat at 3:05 p.m. ET).
Webcast links will be available on the company’s Investor Relations website. AdaptHealth operates four reportable segments and serves about 4.5 million patients annually across ~670 locations in 48 states.
AdaptHealth (NASDAQ: AHCO) reported Q1 2026 results: net revenue $819.8M (+5.4% vs. Q1 2025) and organic revenue +9.1%. The company completed a major de novo expansion, grew registered myApp users to 412,000 (+26% QoQ), and closed a $1.1B refinancing in April 2026. Q1 adjusted EBITDA was $121.2M (down 5.3%); net loss attributable to AdaptHealth was $16.0M. Free cash flow was negative $27.5M. Management raised 2026 revenue guidance by $10M to $3.45B–$3.52B while maintaining adjusted EBITDA and free cash flow targets.
AdaptHealth (NASDAQ: AHCO) will release first quarter 2026 financial results before market open on Tuesday, May 5, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss results with analysts and investors.
Dial-in numbers are provided with Conference ID AHCO1Q26; a webcast registration link and a replay available for six months on the company's Investor Relations site.